László Landherr

6.0k total citations
20 papers, 191 citations indexed

About

László Landherr is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, László Landherr has authored 20 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in László Landherr's work include Breast Cancer Treatment Studies (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (5 papers). László Landherr is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (5 papers). László Landherr collaborates with scholars based in Hungary, United States and Russia. László Landherr's co-authors include Guy Jérusalem, Bent Ejlertsen, Mustafa Özgüroğlu, Howard A. Burris, Marianne Ewertz, Sara A. Hurvitz, Tetiana Taran, Denise A. Yardley, Richard H. De Boer and Sibel Blau and has published in prestigious journals such as Journal of Clinical Oncology, JAMA Oncology and The Breast.

In The Last Decade

László Landherr

19 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Landherr Hungary 8 122 62 61 42 34 20 191
Sreelakshmi Mallappa United Kingdom 6 146 1.2× 32 0.5× 50 0.8× 56 1.3× 23 0.7× 14 219
Silvana Acquafredda Italy 6 159 1.3× 94 1.5× 40 0.7× 42 1.0× 8 0.2× 8 237
Giorgio Bonciarelli Italy 9 161 1.3× 57 0.9× 95 1.6× 28 0.7× 9 0.3× 21 265
Nur Sabrina Sapari Singapore 7 67 0.5× 48 0.8× 52 0.9× 110 2.6× 17 0.5× 15 199
Yakup Ergün Türkiye 7 122 1.0× 58 0.9× 62 1.0× 30 0.7× 5 0.1× 44 181
Ilaria Depetris Italy 7 119 1.0× 42 0.7× 38 0.6× 45 1.1× 6 0.2× 10 194
Hannah Bye United Kingdom 8 42 0.3× 53 0.9× 35 0.6× 76 1.8× 17 0.5× 14 163
Tamara Saurí Spain 9 107 0.9× 45 0.7× 41 0.7× 65 1.5× 7 0.2× 30 226
Mustafa Karaağaç Türkiye 8 142 1.2× 69 1.1× 47 0.8× 33 0.8× 7 0.2× 51 229
Baohong Yang China 11 69 0.6× 37 0.6× 70 1.1× 67 1.6× 21 0.6× 26 262

Countries citing papers authored by László Landherr

Since Specialization
Citations

This map shows the geographic impact of László Landherr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Landherr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Landherr more than expected).

Fields of papers citing papers by László Landherr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Landherr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Landherr. The network helps show where László Landherr may publish in the future.

Co-authorship network of co-authors of László Landherr

This figure shows the co-authorship network connecting the top 25 collaborators of László Landherr. A scholar is included among the top collaborators of László Landherr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Landherr. László Landherr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polgár, Csaba, et al.. (2022). Radiotherapy of Breast Cancer—Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer. Pathology & Oncology Research. 28. 1610378–1610378. 20 indexed citations
2.
Boér, Katalin, László Landherr, Tibor Csőszi, et al.. (2021). Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience. Pathology & Oncology Research. 27. 1609785–1609785. 9 indexed citations
3.
Landherr, László, et al.. (2021). [Secondary lung cancer risk after breast cancer radiation therapy. The benefits substantially overweight the minimal disadvantages].. PubMed. 65(1). 46–52. 2 indexed citations
4.
Vacirca, Jeffrey, Arlene Chan, Zsuzsanna Pápai, et al.. (2018). An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer. Cancer Medicine. 7(5). 1660–1669. 10 indexed citations
6.
Jérusalem, Guy, Richard H. De Boer, Sara A. Hurvitz, et al.. (2018). Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor–Positive, HER2-Negative Advanced Breast Cancer. JAMA Oncology. 4(10). 1367–1367. 59 indexed citations
7.
Landherr, László, et al.. (2018). [Alcohol and breast cancer. A short survey].. PubMed. 62(1). 68–71. 2 indexed citations
8.
Landherr, László, et al.. (2018). [Oral contraception and the risk of breast cancer. Review of the literature].. PubMed. 62(4). 258–263. 2 indexed citations
9.
Aapro, Matti, Michelino De Laurentiis, Enrique Bargalló‐Rocha, et al.. (2017). The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?. The Breast. 33. 191–199. 3 indexed citations
10.
Landherr, László, et al.. (2017). [Treatment of bone metastases: bisphosphonates and denosumab].. PubMed. 61(2). 175–180. 5 indexed citations
11.
Salamon, Ferenc, et al.. (2014). Pathologic Assessment of Response to Chemotherapy in Colorectal Cancer Liver Metastases after Hepatic Resection: Which Method to Use?. Pathology & Oncology Research. 21(1). 173–179. 12 indexed citations
12.
Nagy, András, et al.. (2014). Postoperative radiotherapy of breast cancer and cardiotoxicity. Orvosi Hetilap. 155(23). 897–902. 1 indexed citations
13.
Landherr, László, et al.. (2014). Vitamin D and breast cancer. Orvosi Hetilap. 155(28). 1091–1096. 3 indexed citations
14.
Dank, Magdolna, Béla Pikó, László Mangel, et al.. (2014). First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study.. PubMed. 34(3). 1275–80. 11 indexed citations
15.
Besznyák, I, et al.. (2013). Bevacizumab Treatment Before Resection of Colorectal Liver Metastases: Safety, Recovery of Liver Function, Pathologic Assesment. Pathology & Oncology Research. 19(3). 501–508. 8 indexed citations
16.
Landherr, László, et al.. (2011). [Aromatase inhibitors and arthralgia].. PubMed. 55(1). 32–9. 34 indexed citations
17.
Polgár, Csaba, András Csejtei, László Landherr, et al.. (2010). Sugárterápiás irányelvek. PubMed. 54(3). 257–265. 1 indexed citations
18.
Landherr, László, et al.. (2009). Időskorú kolorektális daganatos betegek gyógyszeres kezelése. PubMed. 53(2). 97–105. 6 indexed citations
19.
Landherr, László, et al.. (2009). A távoli áttétes kolorektális rák (mCRC) első választású kezelésének fejlődése. PubMed. 53(3). 237–246. 1 indexed citations
20.
Landherr, László, et al.. (2002). [Pamidronate in the treatment of bone metastases from breast cancer].. PubMed. 46(3). 225–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026